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The Mycobacterium tuberculosis genome has revealed
a remarkable array of polyketide synthases (PKSs);
however, no polyketide product has been isolated thus
far. Most of the PKS genes have been implicated in the
biosynthesis of complex lipids. We report here the char-
acterization of two novel type III PKSs from M. tubercu-
losis that are involved in the biosynthesis of long-chain
-pyrones. Measurement of steady-state kinetic param-
eters demonstrated that the catalytic efficiency of
PKS18 protein was severalfold higher for long-chain
acyl-coenzyme A substrates as compared with the small-
chain precursors. The specificity of PKS18 and PKS11
proteins toward long-chain aliphatic acyl-coenzyme A
(C12 to C20) substrates is unprecedented in the chalcone
synthase (CHS) family of condensing enzymes. Based on
comparative modeling studies, we propose that these
proteins might have evolved by fusing the catalytic ma-
chinery of CHS and -ketoacyl synthases, the two evo-
lutionarily related members with conserved thiolase
fold. The mechanistic and structural importance of sev-
eral active site residues, as predicted by our structural
model, was investigated by performing site-directed mu-
tagenesis. The functional identification of diverse cata-
lytic activity in mycobacterial type III PKSs provide a
fascinating example of metabolite divergence in CHS-
like proteins.
Mycobacteria are classified in the phylogeny of the Actino-
mycetes, along with the Streptomyces bacteria. Interestingly,
these two actinomycete genera have received immense atten-
tion due to their contrasting effects on human society. Whereas
Streptomyces have provided a rich source of antibiotics and
other therapeutic products for human diseases, Mycobacterium
tuberculosis and Mycobacterium leprae have been two of hu-
mankind’s greatest scourges. Although the original phylogenic
classifications of Mycobacterium and Streptomyces were based
primarily on morphology, the genome sequences of these or-
ganisms have further established their common lineage (1, 2).
These genome sequences have revealed several families of
genes that are common between them, which include an un-
usually large number of gene clusters that are homologous to
polyketide synthases (PKSs).1 Although a polyketide product
has not yet been isolated from M. tuberculosis, recent studies
have implicated some of its PKS genes in the biosynthesis of
complex lipids (3). In this report, we have characterized two
novel polyketide synthases from M. tuberculosis, which are
involved in the biosynthesis of unusual long-chain -pyrones.
Polyketides are a diverse class of secondary metabolites that
possess a broad range of biological activities (4). Despite struc-
tural diversity of these natural products, PKSs synthesize
polyketides by a common chemical strategy. Initial priming by
a starter molecule is followed by repetitive decarboxylative
condensation of coenzyme A (CoA) analogues of simple carbox-
ylic acids. PKS elongates the polyketide chain either by repet-
itively using a single active site to perform multiple condensa-
tion reactions or by using a modular assembly line mechanism
(5–7). Based on protein architecture, PKSs have been classified
in three distinct families. Type I PKSs are giant assemblies of
multifunctional polypeptides and include both iterative and
modular mechanism of biosynthesis. Type II PKSs are a large
multienzyme complex of discrete proteins and resemble type II
fatty acid synthases found in bacteria and plants. The type III
PKS has been recently discovered in bacteria and belongs to
the plant chalcone synthases (CHSs) superfamily of condensing
enzymes (8). These are homodimeric proteins and are structur-
ally and mechanistically quite distinct from type I and type II
PKSs (9). Type III PKSs use free CoA substrates without the
involvement of a 4-phosphopantetheine group.
CHSs are ubiquitously present in higher plants and catalyze
biosynthesis of starting materials for many flavonoids (10).
Several new additions to the CHS superfamily, such as acri-
done synthase, 2-pyrone synthase (2PS), and benzalacetone
synthase, deviate from the chalcone biosynthetic model by ei-
ther utilizing non-phenylpropanoid starter units or varying the
number of condensation reactions (11). Some of the plant en-
zymes also show different cyclization patterns, emphasizing
the growing diversity of the CHS superfamily. The three-di-
mensional crystal structures of CHS from Medicago sativa
(alfalfa) (12) and 2PS from Gerbera hybrida (daisy) (13) have
led to a more comprehensive understanding to structurally
rationalize the mechanistic differences between enzymes
within the thiolase family. Presently, the thiolase fold enzymes
can be grouped into three families (11, 14, 15). -Ketoacyl acyl
carrier protein synthase (KAS) I and KAS II proteins comprise
one group, and KAS III and type III PKS form another group.
The third group consists of several thiolases. These enzymes
have a conserved  fold architecture that forms one side of
the active site cavity. The positioning of the catalytic cysteine
with respect to the dimer interface is also conserved in this
family of enzymes. The differences primarily exist in the struc-
tural loops that form the other face of the cavity. The identity
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and the number of the key catalytic amino acid residues might
account for the observed differences in the catalytic machinery.
The crystal structures also provide a framework for developing
structure-based approaches for characterizing other CHS ho-
mologues. Over the past several years, CHS homologues have
also been reported in bacteria. The type III PKS involved in the
biosynthesis of 1,3,6,8-tetrahydroxynaphthalene (THN) has
now been characterized from S. griseus (16), S. erythraea (17),
S. antibioticus (18) and S. coelicolor (19). All of these THN
synthases (THNSs) use malonyl-CoA as starter and extender
units. The chain elongation proceeds through successive decar-
boxylative condensations of C-2 units to form pentaketide,
which is then cyclized into THN. The THNS from S. griseus
(also known as RppA) has been shown to possess broad sub-
strate specificity to yield a wide variety of products (20). In
several strains that produce vancomycin group of natural prod-
ucts, a CHS-like protein performs the biosynthesis of 3,5-dihy-
droxyphenylglycine by using several molecules of malonyl-CoA
as substrate (21–23). The precursor to the broad spectrum
antimicrobial agent 2,4-diacetylphloroglucinol is produced by a
CHS homologue (phlD) in many strains of fluorescent Pseudo-
monas sp. (24). The PhlD protein uses acetoacetyl-CoA and two
molecules of malonyl-CoA to form monoacetyl phloroglucinol,
which is then converted to 2,4-diacetylphloroglucinol.
In this study, we have characterized two type III PKS pro-
teins, PKS18 and PKS11, from M. tuberculosis that are in-
volved in the biosynthesis of long-chain -pyrones. Kinetic
analysis indicated that the catalytic efficiency of PKS18 protein
to use long-chain acyl-CoA substrates is severalfold higher
than that for small-chain substrates. This remarkable specific-
ity of mycobacterial proteins is unprecedented in the family of
CHS-related proteins. Molecular modeling studies suggested
that these proteins might have evolved by combining the active
sites of CHS and KAS proteins, the two mechanistically related
members of the thiolase fold enzymes. The catalytic and struc-
tural importance of several active site residues, as predicted by
our structural model, was investigated by performing site-
directed mutagenesis. These studies thus reveal a new class of
function in this protein superfamily.
EXPERIMENTAL PROCEDURES
Materials—BAC genomic library of M. tuberculosis was obtained
from Prof. Stewart Cole of Pasteur Research Institute (1). [2-14C]Malo-
nyl-CoA (58.40 mCi/mmol) was procured from PerkinElmer Life Sci-
ences, and nonradioactive acyl-CoA starter substrates were purchased
from Sigma. Plant-specific starter substrates were kindly donated by
Joseph P. Noel’s group. [2-14C]Lauroyl-CoA (57 mCi/mmol) was synthe-
sized using an acyl-CoA synthetase protein.2
Cloning, Expression, and Purification—Type III PKS genes, pks10,
pks11, and pks18, were amplified by PCR from the BAC genomic library
of M. tuberculosis using gene-specific primers and cloned into pBlue-
script SK (Stratagene). The authenticity of clones was confirmed by
automated nucleotide sequencing. These genes were subcloned into the
pET21c vector system (Novagen) and expressed as C-terminal hexahis-
tidine-tagged proteins in the BL21/(DE3) strain of Escherichia coli.
Optimum soluble expression was achieved by growing cultures at low
temperature. Whereas induction at 22 °C with 0.5 mM isopropyl-1-thio-
-D-galactopyranoside led to expression of PKS18 in soluble form,
PKS11 protein (20%) was obtained in the supernatant by growing
uninduced cultures at 18 °C for 24 h. Under the experimental condi-
tions tested, PKS10 persistently expressed as inclusion bodies and
could not be rescued in the soluble form. Proteins were partially puri-
fied using Ni2-nitrilotriacetic acid-agarose (Qiagen) and further re-
solved on a Resource Q anion exchange column (Amersham
Biosciences).
Mutagenesis—PKS18 mutants A148T, A148M, A148F, L348S, and
K318A were generated using the QuikChange site-directed mutagene-
sis kit (Stratagene). Mutagenesis reaction was carried out in accordance
with the manufacturer’s protocol. Mutant clones were screened by re-
striction endonuclease digestion and confirmed by automated DNA
sequencing. All of the mutant proteins were expressed and purified
analogous to the wild type PKS18 protein. A148T, A148M, and A148F
mutants expressed as inclusion bodies and could not be expressed in
soluble form.
Enzyme Assay and Product Characterization Using Mass Spectrom-
etry—The standard reaction conditions involved 100 M starter mole-
cule and 50 M malonyl-CoA (inclusive of 9.12 M [2-14C]malonyl-CoA
(58.40 mCi/mmol)). Reactions were carried out with 45 g of protein at
30 °C for 10–60 min and quenched with 5% acetic acid. Products were
extracted with 2  300 l of ethyl acetate and dried under vacuum.
Radiolabeled products were resolved on silica gel 60 F254 TLC plates
(Merck) in ethyl acetate/hexanes/acetic acid (63:27:5, v/v/v). Reaction
products were resolved on reverse phase columns (Phenomenex). A
linear gradient of 30% CH3CN in H2O (each containing 2% acetic acid)
to 60% CH3CN in H2O over 30 min was used for separating hexanoyl-
CoA-primed reaction products. Products of lauroyl-CoA-primed reaction
were separated using a solvent system of 20 mM ammonium acetate, pH
5.4 (solvent A), and CH3CN/CH3OH (42.5:7.5, v/v) (solvent B).
Polyketide products were characterized using nanospray electrospray
ionization (ESI)-mass spectrometry (MS) (API QSTAR Pulsar i MS/MS;
Applied Biosystems).
Determination of Kinetic Parameters—A standard reaction volume of
75 l contained 100 M malonyl-CoA, inclusive of 9.12 M [2-14C]malo-
nyl-CoA (58.40 mCi/mmol), 45 g of protein, 50 mM Tris, pH 7.5, 1 mM
EDTA, 1 mM dithiothreitol, 10% glycerol and varied (0.5–200 M)
starter molecule concentrations. Reactions were preincubated at 30 °C
for 2 min, initiated by the addition of substrates, and then continued for
3 min. Products were extracted with 2  300 l of ethyl acetate after
quenching the reaction with 5% acetic acid. The organic layer was
vacuum-dried and run on silica gel 60 F254 TLC plates (Merck) as
described above. Resolved radiolabeled products were quantified using
a Fuji FLA-5000 phosphor imager.
Substrate Binding Assays—30 g of protein was incubated with
[2-14C]malonyl-CoA (58.40 mCi/mmol) or [2-14C]-lauroyl CoA (57 mCi/
mmol) for 15 min at 30 °C. Reactions were quenched by the addition of
SDS gel loading dye and resolved on SDS-PAGE. Radioactivity bound to
the proteins was detected using a Fuji FLA-5000 phosphor imager.
Malonyl-CoA Decarboxylase Assay—A reaction volume of 20 l con-
taining 24 g of protein and 34.2 M [2-14C]malonyl-CoA (58.40 mCi/
mmol) was incubated at 30 °C for 30 min. Reactions were quenched
with 6 M HCl and applied directly on silica gel 60 F254 TLC plates
(Merck). A solvent system of isopropyl alcohol/H2O/25% aqueous am-
monia (80:5:15, v/v/v) was used to resolve malonyl-CoA and acetyl-CoA.
The RF of these compounds was determined using authentic standards.
Structural Modeling Studies—The sequences of various CHS-like
proteins were downloaded from GenBankTM (25) and structures of
various enzymes of thiolase fold family were obtained from the Protein
Data Bank (26). All pairwise alignments were carried out using BLAST
(27) at NCBI and ClustalW program (28) from the EBI server was used
for generating multiple alignments and dendrograms. The active site
cavities in various structures were identified by using the program
ACSITE. The 3D-PSSM server was used for threading calculations.
Structural superpositions were carried out using CE server (29). Struc-
tural models were generated using the rotamer library approach of the
SCWRL program and the INSIGHT II package (version 2.3.5; Biosym
Technologies, San Diego) was used for energy minimization and depic-
tion of structural models.
RESULTS
Homology-based Structure/Function Analysis of Type III
PKS Proteins—The genome sequencing projects of various mi-
crobes have resulted in identification of several genes similar to
type III PKSs. A number of CHS homologues are present in S.
coelicolor, Bacillus subtilis, Bacillus halodurans, Deinococcus
radiodurans, Cytophaga hutchinsonii, and M. tuberculosis (8).
Although none of the type III PKS identified through genome
sequencing efforts has been characterized, these results sug-
gest that type III PKS is prevalent in bacteria as well. Our
analysis of mycobacterial genome sequences revealed three
type III PKS genes in M. tuberculosis. Two of these genes,
pks10 and pks11, are annotated putative chalcone synthases,
whereas pks18 (which shows similar sequence similarity) is
surprisingly listed as a conserved hypothetical protein in the
revised M. tuberculosis genome annotations (30). The pks102 P. Arora and R. S. Gokhale, unpublished results.
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and pks11 genes are clustered in an unusual organization with
other PKS genes that encompass 18 kb of genomic DNA. The
pks18, on the other hand, is not flanked by any PKS-related
genes. All three genes are completely conserved in M. bovis
BCG, suggesting their functional relevance in mycobacteria.
Comparative analysis of protein sequences of plants and
microbial type III PKSs have previously led to the clustering of
these proteins based on species. The dendrogram based on
complete protein sequences had two major branches corre-
sponding to plants and microbial PKSs; further categorization
within the plant family was not feasible (8, 17). Since protein
sequence diversity between plant and bacterial type III PKSs
correlates with functional differences between the two systems,
it is possible that the active site residues in the catalytic pocket
can facilitate more reliable clustering. Similar active site se-
quence analyses of acyl transferase domains from modular
PKSs (31) and adenylation domain of nonribosomal peptide
synthetases (32) have indicated much better correlation with
their functions. Fig. 1 shows a dendrogram of all microbial and
some of the plant type III PKSs, constructed by using 32 active
site residues that have been identified in the three-dimensional
structure of CHS. The product biosynthesized by the corre-
sponding PKS is drawn next to its branch (proteins and their
products are drawn in the same color). It can be noticed that all
the plant polyketide synthases cluster together. The eight CHS
proteins that have been selected randomly have identical sets
of active site residues. Interestingly, the plant PKSs associated
with divergent products appear at different branches in the
dendrogram, which was not the case when analysis was done
with the entire protein sequence. The three distinct types of
bacterial type III PKSs that have been experimentally charac-
terized also cluster in three distinct branches. Here again we
observe that active site residues are completely conserved
among their family members. This trend of complete conserva-
tion of active site residues may be a manifestation of biased
data set, since most of the sequences are available from the
same genus. There are presently seven protein sequences in
the THN synthase family, and six of them have been experi-
mentally characterized. It can be predicted with reasonable
confidence that the seventh sequence would also be involved in
THN biosynthesis, which was also recently suggested by Aus-
tin and Noel (11). This protein was probably wrongly annotated
as PhlD homologue during S. avermitilis genome sequencing
(33). Several PhlD homologues from Pseudomonas fluorescens
also possess an identical set of active site residues, indicating
that they are involved in the biosynthesis of the same metab-
olite. The other bacterial type III proteins of unknown function
are present in a separate branch in the dendrogram. Although
several important catalytic and structural residues are con-
served, these CHS-like enzymes from bacterial genomes have
significant variation at several amino acid positions. Our se-
quence comparison analysis therefore could not predict puta-
tive function of mycobacterial type III PKSs. In order to char-
acterize the function of these mycobacterial type III PKSs, we
have used two distinct approaches. In the genetic-based ap-
proach, the pks10-pks11 cluster of mycobacteria has been
FIG. 1. Phylogenetic analysis of plant and bacterial type III PKSs. The dendrogram was generated for all bacterial and a few represent-
ative plant sequences using 32 residues corresponding to the alfalfa chalcone synthase (Protein Data Bank code 1CGZ) active site amino acids.
Each protein and its polyketide product are drawn in the same color. The uncharacterized proteins are shown in black (gi numbers are shown in
parenthesis). Mycobacterial type III PKSs have been underlined in pink.
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knocked out by using double recombination.3 The metabolic
profiles for the wild type and mutant Mycobacteria can reveal
the function of PKS genes. The results of this study would be
discussed elsewhere.
In the structure-based approach, we have probed the differ-
ences in the initiation/elongation cavities of all three mycobac-
terial CHS homologues. The chimeric models of PKS10, PKS11,
and PKS18 were constructed by replacing variable amino acids
in the catalytic pocket of alfalfa CHS (Protein Data Bank code
1CGZ) by analogous residues in these proteins. For example,
the PKS18 chimeric model was constructed by replacing 11 of
32 residues that constituted the initiation/elongation cavity of
CHS. The amino acid replacements were carried out by the
rotamer library approach using the SCWRL program (34). This
comparative modeling approach is based on the premise that
the overall fold as well as the active site geometry of protein
would be similar. In one such successful attempt, CHS was
transformed into 2PS by introducing bulkier side chains at
three crucial positions (13). The reduction in cavity volume
matched with the change in usage of the starter substrates,
number of extensions, and final cyclization. However, similar
homology models with stilbene synthases have failed to iden-
tify the structural basis for alternative cyclizations (11). The
comparison of CHS and stilbene synthase three-dimensional
structures has attributed these cyclization differences to subtle
active site changes, apparently involving electronic rather than
steric interactions. Although this example illustrates the pit-
falls of homology modeling, it should be noted that the homol-
ogy modeling predictions are more reliable at the gross level
than for subtle rearrangements. Fig. 2 compares the active site
cavities of chimeric models generated for mycobacterial type III
PKSs with that of the experimentally determined structure of
CHS. Chimeric models were also generated for 2PS and THNS
for comparisons. The presence of three amino acids, Leu202,
Leu261, and Ile343, in 2PS considerably decreases the cavity
volume due to increased steric bulk of these residues, as ob-
served in its three-dimensional crystal structure (13). This
provides support to the validity of homology-based active site
predictions. In the chimeric model of THNS, these three posi-
tions correspond to Cys171, Tyr224, and Ala305. The changes of
Tyr and Cys are compensatory in terms of changes of the cavity
volume for THNS. In PKS10 and PKS11, Gly256 of CHS (cor-
responding to Leu261 of 2PS) is changed to Tyr and Trp, respec-
tively. Although there is a reduction in the volume of the cavity
compared with CHS, substrate preference of these proteins is
not apparent from these homology-modeled chimeric struc-
tures. In contrast, the PKS18 homology model shows remark-
able constriction in the active site cavity. The steric bulk from
three active site residues, Asn208, Leu266, and Leu348, signifi-
cantly affects the active site volume. We therefore predicted
that PKS18 protein might resemble 2PS and may catalyze
biosynthesis of pyrones. In order to improve our predictability
for PKS10 and PKS11, various CHS-related plant products
were docked in the initiation/elongation cavity. Most of these
docked structures resulted in steric clashes with the protein
side chains and backbone, suggesting that p-coumaroyl-CoA-
like starter units may not be a substrate for these proteins.
Characterization of Mycobacterial Type III PKSs—Three my-
cobacterial type III PKSs showed 40–45% similarity with both
plant and bacterial CHS-like sequences. These genes were
cloned from the H37Rv BAC genomic library and were then
expressed in E. coli using the T7 expression system. Although
overexpression for all three proteins, PKS10, PKS11, and
PKS18, was observed, most of the protein was present in in-3 Yogyata and R. S. Gokhale, unpublished results.
FIG. 2. Comparison of the active site cavities of mycobacterial PKS10, PKS11, and PKS18 proteins with the experimentally
determined CHS initiation/elongation cavity complexed with resveratrol (1CGZ). Some of the crucial active site residues along with the
catalytic Cys (in red) are shown here. Chimeric models of PKS10, PKS11, and PKS18 were generated by amino acid replacements using the SCWRL
amino acid rotamer library. The 2PS and THNS chimeras were constructed for comparison. 2PS cavity resembles the crystallographically
elucidated structure validating the homology-based active site predictions. Since active site cavity is buried, two residues were removed for clarity.
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clusion bodies. The PKS11 protein was purified from inclusion
bodies and was used to raise polyclonal antibodies. The expres-
sion of PKS18 protein was modulated to soluble form by induc-
ing cultures with a low isopropyl-1-thio--D-galactopyranoside
concentration at 22 °C. PKS11 protein could be purified in the
soluble form by growing cultures without induction at 18 °C for
24 h. The antiserum generated from PKS11 protein specifically
recognized the recombinant hexahistidine-tagged 40-kDa pro-
tein, and no other cross-reacting bands were observed. PKS11
antiserum was also able to weakly recognize PKS18 protein,
which may be a result of homology between these two proteins.
Despite our best efforts, PKS10 protein could not be expressed
in soluble form. PKS18 and PKS11 proteins were purified by
using Ni2-nitrilotriacetic acid affinity chromatography and
were then purified to homogeneity using anion exchange chro-
matography. The identities of proteins were confirmed by N-
terminal protein sequencing and mass spectrometry.
Although our modeling studies predicted that mycobacterial
proteins would not be able to use plant-specific CoA-esters, we
investigated the function of these proteins with several differ-
ent CoA-esters due to their sequence similarity with plant
PKSs. Several plant-specific CoA-esters were incubated with
PKS18 and PKS11 proteins along with radiolabeled malonyl-
CoA. Analysis of the reaction mixture by TLC showed one faint
radioactive band for PKS18 reactions with an RF value differ-
ent from that of the expected plant products. Further exami-
nations with longer time incubations clearly showed that
PKS18 protein could synthesize this product from malonyl-CoA
itself. Since 2PS uses acetyl-CoA as a starter substrate, we
incubated PKS18 protein with acetyl-CoA and [2-14C]malonyl-
CoA. Under the assay condition used in this study, there was
no significant change in the product formation. Since PKS11
protein did not show any appreciable activity under these con-
ditions, we proceeded to identify the PKS18 reaction product.
Remarkable Substrate Specificity for PKS18 Protein—Type
III PKSs such as CHS and THNS have been shown to have
rather promiscuous starter unit specificity (20, 35). However,
in most cases the incorporation of suboptimal moiety has often
adversely affected the catalytic activity, both in terms of for-
mation of end products and in the amount of products. Since
PKS18 protein did not exhibit any activity with plant-specific
acyl-CoA substrates, we used several medium- and long-chain
fatty acid CoA-thioesters as starter substrates. Fig. 3 shows
radio-TLC of a 10-min assay performed using several starter
units and [2-14C]malonyl-CoA as extender substrate with
PKS18 protein. It can be noticed that several significant bands
appear on the TLC plate, particularly for the long-chain acyl-
CoA esters. There is a systematic increase in the RF value of
the products with increasing length of the fatty acyl chain,
clearly indicating that PKS18 protein is able to use medium-
and long-chain aliphatic acyl-CoAs as substrates. Whereas in-
cubation of PKS18 protein with hexanoyl-CoA shows one major
product, incubation with long-chain acyl-CoAs (C12 to C20) pro-
duces two significant products. Under the assay conditions
used in this study, no activity was detected for small-chain,
aromatic, and branched-chain acyl-CoA analogues. These stud-
ies clearly suggested that PKS18 protein can extend long-chain
acyl-CoA substrates by using malonyl-CoA as an extender mol-
ecule to synthesize polyketide products.
Identification of Novel Reaction Products—Polyketide prod-
ucts biosynthesized from purified enzymes were separated on
reverse phase HPLC and characterized by nanospray ESI MS.
Since hexanoyl-CoA-primed reaction showed a reasonable
amount of product on radio-TLC assays, we proceeded to char-
acterize this product. The HPLC profile showed a single major
peak a at 280 nm (Fig. 4A). Incubation of PKS18 with
[2-14C]malonyl-CoA along with hexanoyl-CoA as starter gave
one major radioactive product that co-migrated with the peak
a. This product was then subjected to nanospray MS analysis,
and a molecular ion peak (M-H) at m/z 181.08 was observed.
Based on our understanding of polyketide biosynthesis, this
molecular mass is possible for a cyclized triketide synthesized
from one molecule of hexanoyl-CoA and two molecules of mal-
onyl-CoA. In order to characterize products from lauroyl-CoA, a
ternary solvent system was developed, where the two main
products could be separated as shown in Fig. 4B. Nanospray
mass spectrometric analysis showed molecular ion peaks (M-
H) at m/z 265.17 for c and m/z 307.20 for b, which could be
expected from triketide and tetraketide products, respectively,
of lauroyl-CoA reactions with extensions from malonyl-CoA.
Tetraketide products of type III PKSs are known to cyclize in
three distinct ways, where different polyketide products are
formed from aldol condensation, Claisen condensation, and
lactonization of the reaction intermediate (10, 11). The struc-
tural elucidation of PKS18 reaction products was completed by
using tandem mass spectrometry. Fig. 4C shows the fragmen-
tation pattern for the molecular ion (M-H) m/z 307.20 (ob-
tained for b), which yielded a fragment of m/z 125.03 corre-
sponding to (C6H5O3)
 and m/z 263.21 corresponding to (M-
CO2-H)
 ion. This fragmentation pattern has been previously
reported for the tetraketide -pyrones biosynthesized by RppA
from S. griseus (20). The molecular ion peak (M-H) at m/z
265.17 for c yielded a (M-CO2-H)
 peak at m/z 221.18, which
indicated the presence of an -pyrone ring (Fig. 4D). Products
biosynthesized by PKS18 protein with other acyl chains were
similarly characterized by nanospray MS and determined to be
triketide and tetraketide -pyrones.
The starter unit specificity of PKS18 was investigated by
performing steady state kinetic analysis using C2-C20 acyl-CoA
substrates. PKS18 protein obeyed saturation kinetics in re-
sponse to the increasing concentration of acyl-CoA substrates,
which is summarized in Table I. It can be observed that the
kcat/Km values for the biosynthesis of triketide pyrones of long-
chain acyl-CoA substrates are severalfold higher than that
observed for small-chain substrates. Specificity of PKS18 pro-
FIG. 3. TLC based analysis of radiolabeled products of PKS18.
Reactions were carried out for 10 min using [2-14C]malonyl-CoA as an
extender unit along with different starter substrates. The starter sub-
strates used in the assay are indicated above each lane.
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teins for long-chain acyl-CoA starters, as reflected in the Km
values, is similar for C12 to C20 acyl chains. Aliphatic CoA
substrates longer than C20 were not investigated in this study.
This unusual specificity toward long-chain aliphatic fatty acids
is unparalleled in the CHS family of condensing enzymes.
Previous studies have shown octanoyl-CoA to be the largest
starter unit extended by CHS and THNS (20, 35).
Based on this unusual ability of CHS-like proteins to use
long-chain substrates, reactions were carried out with PKS11
protein using medium- and long-chain acyl-CoA units. Fig. 5
shows the radio-TLC of reactions of PKS11 and PKS18 pro-
teins. As can be visualized, various different products were
obtained when the proteins were incubated for 1 h with these
acyl-CoA starters and [2-14C]malonyl-CoA. Like PKS18,
PKS11 readily accepted these starter units and formed -py-
rone products, as confirmed by nano-ESI-MS (data not shown).
Structural Analysis of Long-chain Specificity for Mycobacte-
rial Proteins—The analysis of the structural models of PKS10,
PKS11, and PKS18 proteins clearly indicated that the putative
CHS active site cannot accommodate pyrone rings with long
aliphatic side groups, suggesting the possibility of an altered
binding pocket in these type III PKS proteins from M. tuber-
culosis. It is interesting to note that some members belonging
FIG. 4. Identification of PKS18 products. HPLC profile was monitored at 280 nm. A shows the superimposition of radioactive measurements
(dotted line) on the 280-nm measurement (continuous line) for hexanoyl-CoA-primed reaction (major product peak is marked a). B shows the HPLC
chromatogram for products formed from lauroyl-CoA-primed reaction (marked b and c) separated using a ternary gradient system. The molecular
mass obtained for each peak by nanospray mass spectrometric analysis is indicated below the structures for the expected products. C and D
illustrate the fragmentation pattern observed by tandem mass spectrometry for lauroyl-CoA-primed products tetraketide pyrone (M-H) 307.20
(C) and triketide pyrone (M-H) 265.17 (D). Fragment ions are indicated above the corresponding peaks. The structure of the molecule with the
expected fragmentation profile is drawn beside its MS/MS spectra.
TABLE I
Steady state kinetic parameters for
PKS18 protein with different starter units
Results are means (n  3) with S.E. values less than 15%.
kcat Km kcat/Km
min1 M s1 M1
Acetyl-CoA 0.045 49.2 15.2
Malonyl-CoA 0.017 58.4 4.8
Hexanoyl-CoA 0.33 19.2 286.4
Lauroyl-CoA 13.94 4.2 55317.4
Palmitoyl-CoA 15.83 5.4 48858.2
Arachidoyl-CoA 15.47 6.1 42267.7
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to the thiolase fold family possess the capability to use long
aliphatic chains as substrates (15, 36, 37). The analysis of the
three-dimensional crystal structure of KAS III enzyme (1HZP)
from M. tuberculosis (referred to as mtFabH) has revealed the
mechanism by which it can catalyze the decarboxylative con-
densation of bulky myristoyl-CoA with malonyl-acyl carrier
protein. Apart from the overall thiolase  fold, KAS III
and CHS-like proteins also share the Cys-His-Asn catalytic
triad. The structural superposition of 1HZP on 1CGZ, as shown
in Fig. 6A, gives a root mean square deviation of 2.9 Å at a Z
score of 6.8. The  core of the two structures superposes
quite well, and the differences are restricted to the loop regions.
The catalytic triad also superposes with a root mean square
deviation of 0.54 Å. It is interesting to note from Fig. 6A that
the two active site cavities (red dots for CHS and green dots for
KAS III) are oriented differently with respect to the CoA-
binding tunnel. Whereas the KAS III orients the starter units
to the right and toward the dimer interface, CHS orients them
toward the left. Unlike CHS, mtFabH enzyme can elongate
long-chain aliphatic chains and has been shown to be specific
for C8 to C20 aliphatic substrates (36). The structural basis of
the substrate specificity for six priming ketosynthases was
investigated recently (36, 38). These studies indicated that the
selectivity and primer unit size are primarily controlled by the
side chains of three residues from the loops present close to the
dimer interface. In mtFabH, all of the side chains of the cavity-
limiting residues (Asn90, Thr96, and Glu200) are either short or
point outwards, resulting in a long tunnel. A recent review
article has discussed the structural and mechanistic implica-
tions of various members of the thiolase family of enzymes (11).
Since mycobacterial type III PKSs biosynthesize products
that have characteristics of both CHS and KAS III proteins, we
set out to test the hypothesis that these enzymes would have
evolved by combining the two catalytic centers of CHS and KAS
III. PKS18 displays a homology of 42% with alfalfa CHS over
the entire protein sequence. As described earlier, a compara-
tive model of PKS18 based on 1CGZ structure was constructed,
which demonstrated a constricted CHS initiation/elongation
cavity. In the CHS-related structural family of condensing en-
zymes, several proteins such as mtFabH use long-chain sub-
strates. The attempt to model long-chain aliphatic substrate in
the putative active site of PKS18 was tested by using 1HZP as
template. Sequence similarity of PKS18 to mtFabH is re-
stricted to a small region consisting of amino acids 111–239.
The C-terminal domain does not show any homology with
PKS18 in sequence comparisons. Since threading methods are
capable of detecting structural similarity at low sequence iden-
tities, PKS18 was threaded using the 3D-PSSM server (39).
The threading results indicated the plant CHS structure
(1CGZ) to be the highest scoring fold, although the structure of
mtFabH (1HZP) was also suggested to be a possible template.
Upon detailed inspection of the alignments given by the thread-
ing servers, it was found that 3D-PSSM gives a lower score for
1HZP due to poor alignment of the 90 N-terminal residues.
Deletion of 90 N terminus residues improved the threading
score (3D-PSSM E-value from 1.17 to 0.037) and thus provided
an optimal alignment of PKS18 sequence on the structural fold
of mtFabH. However, plant CHS structure was still the highest
scoring fold. We decided to use 1HZP as a template for homol-
ogy modeling, since this protein is known to bind long-chain
aliphatic substrates. Using the program ACSITE (40), an elon-
gated cavity was identified in mtFabH along the dimer inter-
face, indicating that elongated substrate can be accommodated
in the active site of the 1HZP fold. Since the mtFabH coordi-
nates complexed with substrate are not available in the Protein
Data Bank, lauric acid was modeled in the active site of PKS18
using the information from the crystal structure of lauric acid-
KAS I complex (1EK4) (37). Although KAS I proteins have no
detectable sequence homology to the CHS family of condensing
proteins, crystal structure analysis has revealed a conserved
thiolase fold (41). Superposition of the substrate-bound 1EK4
on 1HZP indicated that the transformed substrate fits in the
FIG. 5. Comparative TLC of radiolabeled products of PKS11 and PKS18 proteins. Lanes 1 and 2, hexanoyl-CoA-primed reactions; lanes
3 and 4, lauroyl-CoA-primed reactions. [2-14C]malonyl-CoA was used as an extender unit in all of the reactions. Chemical structures of the major
products are indicated beside the radioactive bands.
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cavity of 1HZP. These transformed coordinates were then used
as starting orientation in the active site of 1HZP fold. The
amino acids of 1HZP that were in contact with the lauric acid
were replaced with equivalent residues of PKS18 based on
threading alignment. The carboxyl carbon of the lauric acid
was covalently attached to the thiol of active site cysteine, and
the complex was energy-minimized using the CVFF force field
(42). The energy-minimized structural model of PKS18 com-
plexed with covalently tethered lauric acid is shown in Fig. 6B.
The residues in contact with the substrate form a hydrophobic
acyl-binding channel, and no steric clashes were observed.
These observations offer a structural model for understanding
the unusual substrate specificity of PKS18 protein.
Probing the Active Site of PKS18 Protein by Site-directed
Mutagenesis—Structural analysis has provided a testable
model to probe into the functional relevance of catalytic and
structural residues of mycobacterial PKSs. Our modeling stud-
ies in conjunction with the analysis of the substrate specificity
for priming ketosynthases suggested that amino acid residue
Ala148 from PKS18 may be a crucial residue. CHS contains a
Met137 residue at the equivalent position, which is contributed
from the second monomer and lines the active site cavity. It can
be observed from Fig. 6A that the Met137 amino acid restricts
the extension of the CHS cavity (red dots) further into the
acyl-chain binding pocket (green dots). The Ala148 residue in
PKS18 was mutated to bulkier side chains of threonine, me-
thionine, and phenylalanine to restrict the extension of the
cavity. Similar strategy was previously successfully employed,
where the KAS II specificity was modulated to favorably accept
shorter acyl-chain length substrates (43). Mutation of the
Ala148 residue of PKS18 protein resulted in expression of these
three proteins in inclusion bodies. Despite our best efforts,
these mutant proteins could not be recovered in the soluble
form. Although we could not directly probe the functional sig-
nificance of this residue, it can be inferred that Ala148 may be
a structurally important residue.
Another residue predicted to be involved in the formation of
active site cavity, Leu348 of PKS18, was investigated by per-
forming mutagenesis studies. Previous mutagenesis studies of
the equivalent residue in CHS (Ser338) (Fig. 6A) have impli-
cated its role in starter unit selectivity and determination of
the chain length of the growing polyketide (13). Mutation of the
analogous Ala305 residue to a bulkier isoleucine residue in
THNS protein abolished the synthesis of tetraketide pyrones,
and only triketide pyrones were observed (18). In PKS18,
Leu348 was mutated to a smaller serine residue. Biochemical
characterization carried out with [2-14C]malonyl-CoA and the
various starter substrates resulted in a relative increase in the
synthesis of the tetraketide products. Fig. 7 shows the nano-
spray tandem mass spectrometric analysis of the tetraketide
pyrone of the hexanoyl-CoA-primed reaction of L348S mutant.
The wild type PKS18 protein does not synthesize this product.
An increase in the tetraketide product for the L348S mutant
suggested that the Leu348 residue might be located in the
elongation/cyclization cavity of PKS18 protein, consistent with
our homology model.
CHS condensing enzymes contain three conserved basic
amino acid residues that are located at the outer rim of the
CoA-binding tunnel for electrostatic interactions with CoA
phosphates (12). Bacterial type III PKSs contain an extra con-
served basic amino acid residue (Lys318 in PKS18) in proximity
to the predicted CoA-binding tunnel (11). Plant CHSs have a
conserved alanine residue at this position, as shown in Fig. 6A.
The equivalent residue is arginine in several KAS III enzymes,
where the guanidino side chain facilitates the binding of acyl
carrier protein (46). It has been speculated that some bacterial
type III PKSs may also have specificity for ACP-thioester sub-
strates (11). In an attempt to elucidate the role of this con-
served residue, Lys318 of PKS18 was mutated to alanine. The
K318A mutant was unable to synthesize any polyketide prod-
ucts in our standard PKS18 assay. Biophysical analysis of the
mutant protein showed no change in the overall secondary and
tertiary structure as compared with wild type PKS18 protein.
The inactivity of the mutant protein was probed by carrying out
binding assays with radiolabeled starters and extender units.
Fig. 8 shows the autoradiogram of the SDS-PAGE gel contain-
ing wild type PKS18 protein and K318A mutant protein incu-
bated independently with [2-14C]lauroyl-CoA and [2-14C]malo-
nyl-CoA. It can be observed that the wild type PKS18 protein
can be radiolabeled with both malonyl-CoA and lauroyl-CoA
(Fig. 8A). In contrast, the K318A mutant retains the ability to
accept the starter lauroyl-CoA but could not bind to the ex-
tender malonyl-CoA (Fig. 8B). Further mechanistic investiga-
FIG. 6. A, the structural superposition of mtFabH (1HZP) on alfalfa
chalcone synthase (1CGZ). The two active site cavities predicted by
ACSITE are marked on the structure (red dots for CHS and green dots
for mtFabH). It can be observed that the two active site cavities have
overlapping regions. The three residues that are mutated in the present
study are shown on the CHS backbone. B, chimeric model of PKS18
(based on 1HZP) in complex with lauric acid (shown in red). The amino
acids lining the acyl binding cavity are replaced with PKS18 residues.
Ligand is acylated at the catalytic cysteine residue (shown in a ball and
stick model).
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tion suggested that this mutant protein was severely impaired
in malonyl-CoA decarboxylation (Fig. 8C).
DISCUSSION
The identification of diverse catalytic activity in mycobacte-
rial type III PKSs provides an intriguing example of metabolic
divergence in CHS-like proteins. Interestingly, the plant pro-
totype CHS protein has not yet been characterized in bacteria.
In this article, we discuss the characterization of two novel type
III polyketide synthases from M. tuberculosis. PKS11 and
PKS18 enzymes have remarkable specificity to use long-chain
aliphatic-CoA analogues (C12 to C20) as starter units to biosyn-
thesize -pyrones. The reaction catalyzed by PKS18 protein is
summarized in Fig. 9. The mechanism of PKS18 protein to
synthesize pyrones was examined to explore whether the py-
rone formation was a result of hydrolysis followed by nonenzy-
matic cyclization or if this was produced by intramolecular
lactonization. The pyrone products of PKS18 were extractable
with organic solvent even without acidification of the reaction
mixture, suggesting that the acidic conditions were not re-
quired for pyrone formation. Although acidification does pro-
mote spontaneous lactonization, it could also stabilize and pro-
mote the extraction into organic solvents of an enzymatically
formed pyrone. Moreover, pyrone products with long aliphatic
chains would enhance extractability of these products in or-
ganic solvents and can complicate the interpretation of results.
The nanospray ESI-MS analysis did not detect any hemiacetal
or carboxylic acid compounds, indicating that the release of
final product proceeded by intramolecular lactonization. A sim-
ilar mechanism of ring closure has been previously proposed for
RppA protein (20).
Pyrone synthases have been previously characterized in
plants (47), although such proteins have not been identified
from the microbial world. Several plant and bacterial type III
PKSs are also known to synthesize lactones as derailment
products upon incorporation of a suboptimal starter moiety (20,
35). However, this often results in relatively less activity.
Whereas the broad starter molecule specificity of PKS18 and
PKS11 enzymes obscures the assessment of in vivo biological
function, the general preference for the type of starter units
(preference of aliphatic or aromatic, smaller or larger, straight-
chain or branched) provides clues about the likely physiological
substrate. This fact combined with the in vivo availability of
CoA-thioesters should determine the biological function. The
notable preference of mycobacterial type III PKSs for long-
chain acyl-CoAs makes it tempting to speculate that these are
the preferred substrates in vivo, although such pyrone-contain-
ing long-chain derived metabolites have not been isolated from
Mycobacterium. It should be noted that M. tuberculosis con-
tains a rich pool of a remarkable array of long-chain and very
long-chain fatty acids (48). Moreover, the M. tuberculosis genome
also includes 36 copies of fadD homologues that are typically
involved in the biosynthesis of acyl-CoA substrates (1).
Comparative modeling studies suggest that the unusual ca-
pability to accept long-chain acyl-CoA substrates might have
evolved by combining the catalytic machinery of CHS and KAS
proteins. Apart from a constricted CHS active site initiation/
elongation cavity, an additional acyl group binding pocket (typ-
ically observed in KAS-related proteins) has been identified
along the dimer interface in these mycobacterial proteins.
Since homology modeling studies at low sequence identity can-
not give unambiguous results, three-dimensional crystal struc-
FIG. 7. Tandem mass spectrometric analysis of hexanoyl tet-
raketide pyrone synthesized by L348S mutant. The molecular ion
peak (M-H) at m/z 223 fragments into m/z 125 corresponding to
(C6H5O3)
 and m/z 179 corresponding to (M-CO2-H)
 ion.
FIG. 8. Biochemical analysis of PKS18 mutant. The autoradiographs of substrate binding assays are shown for wild type PKS18 (A) and
K318A mutant (B). The substrate used for labeling is indicated above the lane. C shows the TLC-based analysis of malonyl-CoA decarboxylation
assay carried out for wild type and mutant protein (K318A).
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ture analysis of PKS18 protein should provide a clear picture.
Based on our structural models, we have investigated the im-
portance of three catalytically crucial amino acid residues of
PKS18 protein. The mutation of Ala148 to threonine, methio-
nine, and phenylalanine resulted in mutant proteins that ex-
pressed persistently in inclusion bodies. Previous structural
analysis of priming ketosynthases (36, 38) and our modeling
studies had suggested that this residue may be important in
dictating long-chain substrate specificity. It is possible that the
mutagenesis to a bulkier residue has destabilized the hydro-
phobic cavity, resulting in unstable protein. The thermo-
dynamic and structural consequences of mutations in the hy-
drophobic cavity are often difficult to rationalize (44, 45). The
CHS elongation/cyclization cavity was investigated by mutat-
ing Leu348 to a smaller Ser residue. The characteristics of this
L348S mutant protein showed increased biosynthesis of tetra-
ketide pyrone product. This catalytic profile corroborated with
other CHS-like proteins, where the presence of a smaller amino
acid residue at the analogous position enhanced the number of
iterations (13, 18). The K318A mutant showed rather interest-
ing characteristics, where the mutant protein could load the
monocarboxylic starter units but lost the capability of using
dicarboxylic malonyl-CoA as a substrate. The K318A mutant
protein was incapable of decarboxylating malonyl-CoA. Similar
studies have previously been reported for a mechanistically
parallel lysine residue from E. coli KAS I, where the K328A
mutant protein could not decarboxylate malonyl-CoA (49). We
predict that this lysine residue may be required very early in
the catalysis, probably acting as a docking station for dicar-
boxylic acid extender units. Although malonyl-CoA is an ex-
tender in almost all plant and microbial type III PKSs, it is
possible that there are variations in the binding of extender
substrate that might influence the catalytic steps of reaction
intermediates. The presence of an additional positively charged
residue adjacent to the outer rim of the CoA binding tunnel in
2PS structure has indicated the possibility of variations in CoA
binding that are permitted within the type III PKS superfamily
(11, 13).
In conclusion, we have characterized two novel type III PKS
proteins that catalyze the formation of -pyrones using long-
chain acyl-CoA substrates. Comparison of the structural and
mechanistic features of thiolase fold enzymes have suggested
that type III PKS proteins might have emerged by the gain of
function from structurally homologous KAS III proteins. The
functional equivalence of mycobacterial type III PKSs to both
CHS and KAS III proteins presents fascinating insights into
the complexity of the evolutionary process.
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